Publications

The world of science is a fascinating one. There’s always new research, innovative developments, intriguing viewpoints. We’re as curious as you are, so we offer genetic- and oncology-specific publications, from published articles to white papers and posters. And there’s much more.

Validation of BCR-ABL1 Test Performance from Whole Blood Stored up to 72 Hours Facilitates Operational Flexibility and Expanding Locally Managed CML Monitoring
Justin Brown, Ph.D. - Presented at ESH iCMLf
Personalizing Risk for FMR1 Premutation Carriers: Insights from over 8000 AGG Test Results
Deepa Eveleigh - Presented at NFXF
A New Powerful PCR-Based Assay for the Molecular Diagnosis of Myotonic Dystrophy Type I
Asuragen collaboration with Necker-Enfants Malades Hospital - Presented at ESHG
Generalization of an Assay System using Repeat-primed PCR and Capillary Electrophoresis to Resolve Multiple AT- and GC-rich Short Tandem Repeats Associated with Neurological Diseases
Gary Latham, Ph.D.
A Comprehensive, Targeted Next-Generation Sequencing Method That Rapidly and Accurately Detects Circulating Tumor DNA Variants at 0.1% Frequency in Plasma Samples
Asuragen collaboration presented at AACR
A Robust PCR/CE Assay Using AmplideX Technology for Rapid and Accurate Genotyping of CAG Repeat Expansions in HTT
Julie Thibert, Ph.D. - Presented at ACMG
A Rapid, High-throughput PCR Fragment-sizing Assay for Quantifying Spinal Muscular Atrophy (SMN1, SMN2) Copy Numbers
Stela Filipovic-Sadic, Ph.D. - Presented at ACMG
An Efficient and Ultrasensitive Next-Generation Sequencing Solution for Profiling Circulating Tumor DNA
Brian Haynes, Ph.D. - Presented at AMP
A Modular Next-generation Sequencing Technology that Couples the Detection of RNA Structural Variants and DNA Mutations in Lung Cancer
Richard Blidner, Ph.D. - Presented at AMP
BCR-ABL1 minor Breakpoint (e1a2) Monitoring Using an Analytically Validated Multiplex Assay
Justin Brown, Ph.D. - Presented at AMP
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top